Back
Gold Fields Vs. Novartis AG Industry Stock Comparison
Buy
66
GFI
Gold Fields
Last Price:
$20.65
Seasonality Move:
1.37%
Buy
71
NVSEF
Novartis AG
Last Price:
$116.60
Seasonality Move:
6.56%
Buy
66
Gold Fields (GFI)
is a Buy
Is Gold Fields a Buy, Sell or Hold?
-
The current Gold Fields [GFI] share price is $20.57. The Score for GFI is 66, which is 32% above its historic median score of 50, and infers lower risk than normal.
-
GFI is currently trading in the 60-70% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
Buy
71
Novartis AG (NVSEF)
is a Buy
Is Novartis AG a Buy, Sell or Hold?
-
The current Novartis AG [NVSEF] share price is $116.60. The Score for NVSEF is 71, which is 42% above its historic median score of 50, and infers lower risk than normal.
-
NVSEF is currently trading in the 70-80% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
GFI Stock Price Chart
What is Gold Fields's stock price today?
-
The Gold Fields share price today is $20.57The current trend is moderately bullish and GFI is experiencing selling pressure, which indicates risk of future bearish movement.
NVSEF Stock Price Chart
What is Novartis AG's stock price today?
-
The Novartis AG share price today is $116.60Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and NVSEF is experiencing slight buying pressure.
GFI Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | 0.91 | Buy |
Relative Strength Index (14 RSI): | 56.07 | Buy |
Chaikin Money Flow: | -3324495 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (18.66 - 20.88) | Buy |
Bollinger Bands (100): | (14.06 - 18.9) | Buy |
NVSEF Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | 1.84 | Buy |
Relative Strength Index (14 RSI): | 61.26 | Buy |
Chaikin Money Flow: | 0 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (107.1 - 113.78) | Buy |
Bollinger Bands (100): | (98.55 - 109.41) | Buy |
GFI Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 21.1 | Sell |
20-day SMA: | 19.94 | Buy |
50-day SMA: | 18.2 | Buy |
200-day SMA: | 16 | Buy |
8-day EMA: | 20.99 | Sell |
20-day EMA: | 20.18 | Buy |
50-day EMA: | 18.6 | Buy |
200-day EMA: | 16.37 | Buy |
NVSEF Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 110.96 | Buy |
20-day SMA: | 111.23 | Buy |
50-day SMA: | 106.01 | Buy |
200-day SMA: | 106.77 | Buy |
8-day EMA: | 112.31 | Buy |
20-day EMA: | 110.66 | Buy |
50-day EMA: | 107.55 | Buy |
200-day EMA: | 104.74 | Buy |
Gold Fields Earnings Growth & GFI Earnings Dates
-
Analysts estimate an earnings increase this quarter of $0.16 per share, an increase next quarter of $0.02 per share, an increase this year of $0.53 per share, and an increase next year of $0.36 per share.
Novartis AG Earnings Growth & NVSEF Earnings Dates
-
Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.00 per share.
Gold Fields Technical Analysis
Mar 11 | Mar 12 | Mar 13 | Mar 14 | Mar 17 | Mar 18 | Mar 19 | Mar 20 | Mar 21 | Mar 24 | |
---|---|---|---|---|---|---|---|---|---|---|
Mar | ||||||||||
11 | 12 | 13 | 14 | 17 | 18 | 19 | 20 | 21 | 24 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |
Novartis AG Technical Analysis
Mar 11 | Mar 12 | Mar 13 | Mar 14 | Mar 17 | Mar 18 | Mar 19 | Mar 20 | Mar 21 | Mar 24 | |
---|---|---|---|---|---|---|---|---|---|---|
Mar | ||||||||||
11 | 12 | 13 | 14 | 17 | 18 | 19 | 20 | 21 | 24 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |